Cutler Group LP Verastem, Inc. Call Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Oct 26, 2021	SELL	$2.54 - $4.07 $4,318 - $6,919	-1,700 Reduced 25.0%	5,100 $1,000
Q2 2021 Jul 19, 2021	BUY	$2.57 - $4.85 $15,933 - $30,069	6,200 Added 1033.33%	6,800 $2,000
Q4 2018 Feb 05, 2019	SELL	$3.23 - $7.01 $16,150 - $35,050	-5,000 Reduced 89.29%	600 $0
Q3 2018 Nov 07, 2018	BUY	$6.86 - $9.97 $7,546 - $10,967	1,100 Added 24.44%	5,600 $6,000
Q2 2018 Aug 10, 2018	BUY	$2.88 - $8.67 $12,960 - $39,015	4,500 New	4,500 $8,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.29B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.